KUMAR AMIT 4

What Happened Amit Kumar, CEO of Anixa Biosciences (ANIX), acquired 5,000 shares on 2026-07-10 in a purchase reported on a Form 4. The shares were acquired at $3.04 per share for a total transaction value of $15,200. This was a purchase (SEC code "P"), which is a direct acquisition rather than a sale or option exercise.

Key Details

• Transaction date: 2026-07-10; Filing date: 2026-07-13 (filed within the SEC’s 2-business-day window).
• Price and size: 5,000 shares at $3.04 per share; total = $15,200.
• Transaction type: Purchase (Form 4 code "P") — filing notes "open market or private purchase," but does not specify which.
• Shares owned after transaction: Not specified in the information provided in this summary.
• Footnotes / plans: No 10b5‑1 plan, tax withholding, or other special footnotes were indicated in the provided transaction details.

Context Purchases by executives are often watched by investors as potentially bullish signals because they increase the insider’s ownership stake, but they do not prove future stock performance. This is a relatively small insider buy in dollar terms ($15.2K). No exercise, gift, or cashless sale occurred — simply an acquisition of shares.